Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-05-19

FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA granted approval of a supplemental application for Zidovudine submitted by Aurobindo Pharma Limited. Zidovudine is an antiretroviral used to treat HIV infec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zidovudine (Zidovudine)

Snippet

SUPPL AP for ZIDOVUDINE (ZIDOVUDINE)